Full history for every metric is available with a Kvantra account
Nanosynth Group Plc (NNN.L)
Key financial summary
Financials in GBP| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
|---|---|---|---|---|---|---|---|
| Total revenue | £m | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating profit | £m | -3 | |||||
| Net profit | £m | -3 | -2 | -1 | -1 | -2 | -4 |
| EPS reported | £ | -0.00 | |||||
| Operating cashflow per share | £ | -0.00 | |||||
| Capex per share | £ | 0.00 | |||||
| FCF per share | £ | -0.00 | |||||
| Free cash flow | £m | -2 | |||||
| Net debt | £m | -4 | |||||
| Book value equity | £m | 5 | |||||
| Book value per share | £ | 0.00 | |||||
| Number of shares | m | 20,694.55 | |||||
| DPS (TTM paid) | £ | 0.00 |
Financial summary
Financials in GBP| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
|---|---|---|---|---|---|---|---|
| Value | |||||||
| P/E TTM | x | - | |||||
| P/B LTM | x | 49.03 | |||||
| P/S LTM | x | 1,164.69 | |||||
| P/FCF LTM | x | -103.00 | |||||
| EV/EBITDA LTM | x | -96.63 | |||||
| EV/Sales LTM | x | 1,146.67 | |||||
| Earnings Yield LTM | % | -1.66% | |||||
| FCF Yield | % | -0.97% | |||||
| Quality | |||||||
| ROE | % | -81.24% | |||||
| ROIC | % | -50.62% | |||||
| Operating margin | % | -1202.4% | |||||
| Gross margin | % | 21.43% | |||||
| FCF/Sales | % | -1130.8% | |||||
| Growth and momentum | |||||||
| EPS Growth YoY | % | - | |||||
| Sales Growth YoY | % | +100.15% | |||||
| Net Income Growth YoY | % | - | |||||
| FCF Growth | % | - | |||||
| Operating Profit Growth | % | - | |||||
| Dividend and capital structure | |||||||
| Dividend Yield | % | 0.00% | |||||
| Dividend Growth | % | 0.00% | |||||
| Payout Ratio | % | 0.00% | |||||
| FCF/Debt | x | - | |||||
| Net Debt/EBITDA | x | 1.52 | |||||
| EBIT/Net interest | x | -4,606.21 | |||||
| Net debt/market cap | % | -1.55% | |||||
| Net debt/Equity | x | -0.76 | |||||
| Gross debt/equity | x | 0.00 | |||||
Company overview
Nanosynth Group Plc, encompassing its various subsidiaries, specializes in the development and practical application of nanoparticles. These microscopic particles are employed across a diverse range of sectors, including animal health and wellbeing, cosmetics, medical applications, agriculture, the food and beverage industry, functional coatings, and electronics. Beyond its core offerings, the company also manufactures anti-viral face masks and is actively engaged in developing various anti-pathogenic products. Established in 2014, the organization previously operated as Remote Monitored Systems plc before rebranding to Nanosynth Group Plc in August 2021. Its corporate headquarters are situated in London, United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Nanosynth Group Plc (NNN.L)
Nanosynth Group Plc, encompassing its various subsidiaries, specializes in the development and practical application of nanoparticles. These microscopic particles are employed across a diverse range of sectors, including animal health and wellbeing, cosmetics, medical applications, agriculture, the food and beverage industry, functional coatings, and electronics. Beyond its core offerings, the company also manufactures anti-viral face masks and is actively engaged in developing various anti-pathogenic products. Established in 2014, the organization previously operated as Remote Monitored Systems plc before rebranding to Nanosynth Group Plc in August 2021. Its corporate headquarters are situated in London, United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free